Hspb7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HSPB7 Protein
| Property | Value |
|----------|-------|
| **Protein Name** | Heat Shock Protein Beta-7 (HspB7) |
| **Gene Symbol** | HSPB7 |
| **UniProt ID** | Q9UBW9 |
| **Molecular Weight** | ~17 kDa |
| **Subcellular Location** | Cytoplasm, Z-disc |
| **Protein Family** | Small heat shock protein family |
| **Associated Diseases** | Dilated Cardiomyopathy, Arrhythmogenic Cardiomyopathy, Myopathy |
HSPB7 (Heat Shock Protein Beta-7) is a small heat shock protein expressed predominantly in cardiac and skeletal muscle. Unlike other sHSPs, HSPB7 has unique tissue distribution and is strongly associated with muscle disease. It forms a distinct branch of the small heat shock protein family with specialized functions in muscle protection[^1].
The HSPB7 protein contains:
- N-terminal domain: Short, divergent region
- Alpha-crystallin domain: Core conserved region
- C-terminal tail: Short extension
| Feature |
Description |
| Alpha-crystallin domain |
~80 aa conserved region |
| Cysteine residues |
Present in some isoforms |
| Oligomerization |
Forms heterooligomers |
| Tissue specificity |
Muscle-enriched |
HSPB7 functions as[^2]:
- Muscle-specific chaperone: Protects muscle proteins
- Cytoskeletal organizer: Associates with Z-disc
- Anti-apoptotic: Inhibits caspase activation
- Cardiac protector: Essential for heart function
- Muscle regeneration: Supports satellite cell function
HSPB7 is highly specific to:
- Cardiac muscle: High expression in heart
- Skeletal muscle: Particularly type 1 fibers
- Low in other tissues: Distinguishes from other sHSPs
HSPB7 interacts with:
- Alpha-B-crystallin (HSPB5)
- HSPB8
- Desmin cytoskeleton
- Z-disc proteins
HSPB7 protects muscle through:
- Chaperone activity: Prevents aggregation
- Cytoskeletal stabilization: Z-disc protection
- Anti-apoptosis: Blocks death pathways
- Autophagy regulation: Quality control
In the heart:
- Essential for contractile function
- Protects against stress-induced damage
- Maintains sarcomere integrity
- Prevents pathological remodeling
In DCM[^3]:
- HSPB7 mutations cause familial DCM
- Loss-of-function mechanisms
- Variable penetrance
- Impaired cardiac function
In ACM:
- Mutations in desmosome genes
- HSPB7 as modifier
- Disease progression
- Sudden cardiac death risk
In muscle disease:
- Rare HSPB7 mutations cause myopathy
- Rimmed vacuolar pathology
- Muscle weakness
- Respiratory involvement
While primarily muscle-expressed:
- Some expression in neural tissue
- Not strongly implicated in neurodegeneration
- May have general chaperone functions
| Tissue |
Expression |
Notes |
| Heart |
Very high |
Primary site |
| Skeletal muscle |
High |
Type 1 fibers |
| Brain |
Very low |
Limited |
| Other organs |
Minimal |
Tissue-specific |
| Strategy |
Approach |
Status |
Notes |
| Gene Therapy |
HSPB7 delivery |
Research |
Cardiomyopathy |
| Small Molecules |
Chaperone activity |
Research |
Enhancement |
| Protein Therapy |
Recombinant HSPB7 |
Research |
Acute treatment |
- Muscle-specific delivery
- Protein stability
- Appropriate dosing
- Route of administration
Hspb7 knockout mice show:
- Cardiac abnormalities
- Reduced stress tolerance
- Muscle pathology with age
- HSPB7 overexpression protective
- Improves cardiac function
- Protects against injury
- Cardiac development studies
- Muscle function models
Current research areas:
- Gene therapy: AAV-HSPB7 for DCM
- Mechanism studies: Structural analysis
- Biomarkers: HSPB7 in disease diagnosis
- Combination therapy: With other sHSPs
- Patient stratification: Genetic testing
The study of Hspb7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wang Y, et al. HSPB7: A muscle-specific sHSP. J Mol Cell Cardiol. 2022;163:78-92. PMID:34762853
- Inoue-Shibui A, et al. HSPB7 in cardiomyopathy. Circ Heart Fail. 2021;14(6):e008532. PMID:34185074
- Liu J, et al. HSPB7 mutations cause myopathy. Neurology. 2022;99(8):e835-e846. PMID:35853892